Prostate Cancer Clinical Trial
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
Summary
The purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) given with prednisone in patients with androgen-independent prostate cancer, who have not had previous chemotherapy, is safe and helps to decrease PSA (Prostate-specific antigen) levels.
Full Description
This study has previously been posted by Berlex, Inc. and Schering AG, Germany.Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc., Schering AG Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer HealthCare Pharmaceuticals, Inc.and Bayer Schering Pharma AG, Germany are the sponsors of the trial.
Eligibility Criteria
Inclusion Criteria:
Must have evidence of confirmed metastatic prostate cancer
Serum testosterone must be less than 50 ng/mL
Disease must be progressing despite anti-androgen therapy
PSA level must be elevated
Additional criteria determined at screening visit
Exclusion Criteria:
Any previous cytotoxic chemotherapy for prostate cancer
Use of any investigational drug in the last 4 weeks
Symptomatic brain tumors requiring radiation to the brain
Active infection
Additional criteria determined at screening visit
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 17 Locations for this study
Fountain Valley California, 92708, United States
Sarasota Florida, 34237, United States
Baltimore Maryland, 21201, United States
Ann Arbor Michigan, 48109, United States
Billings Montana, 59101, United States
Omaha Nebraska, 68198, United States
Bronx New York, 10469, United States
Canton Ohio, 44718, United States
Portland Oregon, 97201, United States
Altoona Pennsylvania, 16601, United States
Fort Worth Texas, 76104, United States
Seattle Washington, 98108, United States
Buenos Aires Ciudad Auton. De Buenos Aires, C1280, Argentina
Buenos Aires , 1406, Argentina
Buenos Aires , C1405, Argentina
Buenos Aires , C1416, Argentina
Córdoba , X5016, Argentina
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.